Evaluation of parenchymal collaterals in patients with meningioma using contrast-enhanced T1 MPRAGE sequence

Elif Gozgec1, Hayri Ogul2, Ibrahim Feyyaz Naldemir3

  • 1Department of Radiology, Medical Faculty, Ataturk University, Erzurum, Turkey.

Neuro-Chirurgie
|March 29, 2025
PubMed
Abstract

Insights

Parenchymal collaterals frequently accompany meningiomas, especially higher-grade tumors with sinus invasion or bone destruction. Tumor size also correlates with collateral development, aiding in diagnosis.

Area of Science:

  • Neuroimaging
  • Oncology
  • Radiology

Background:

  • Post-contrast T1-MPRAGE imaging is standard for meningioma evaluation.
  • Meningiomas can present with leptomeningeal and parenchymal collaterals.

Purpose of the Study:

  • To identify parenchymal collaterals associated with meningiomas using post-contrast T1-MPRAGE.
  • To explore the relationship between collaterals and meningioma characteristics.

Main Methods:

  • Retrospective analysis of 326 meningiomas in 259 patients.
  • Independent review of post-contrast T1-MPRAGE images for collateral presence and localization.
  • Correlation with tumor size, location, histology, and bone/parenchymal changes.

Main Results:

  • Parenchymal collaterals were present in 25% of meningiomas.
  • Collaterals significantly correlated with higher tumor grade (77%), sinus invasion, and bone destruction.
  • Increased tumor size was associated with unilateral and bilateral collateral development.

Conclusions:

  • Parenchymal collaterals are a notable feature in meningiomas.
  • WHO grade 3 histology, sinus invasion, bone destruction, and tumor size predict collateral development.